Market Newsdesk

January 11, 2021 6:03 pm

Associated Banc-Corp to Attend the 2021 KBW Winter Financial Services Symposium on February 10 – 12, 2021

PR Newswire

GREEN BAY, Wis., Jan. 11, 2021 /PRNewswire/ — Associated Banc-Corp (NYSE: ASB) announced today that Philip Flynn, President and CEO; Christopher J. Del Moral-Niles, Executive Vice President and CFO; Dave Stein, Executive Vice President and Head of Consumer and Business Banking; and John Utz, Executive Vice President and Head of Corporate Banking and Wealth Management will meet with investors during the 2021 KBW Winter Financial Services Symposium on February 10 – 12, 2021.

The first quarter investor presentation will be made available prior to the presentation and can be accessed via Associated Banc-Corp’s website at http://investor.associatedbank.com.

ABOUT ASSOCIATED BANC-CORP

Associated Banc-Corp (NYSE: ASB) is one of the top 50 publicly traded U.S. bank holding companies. Headquartered in Green Bay, Wisconsin, Associated is a leading Midwest banking franchise, offering a full range of financial products and services from more than 220 banking locations serving more than 120 communities throughout Wisconsin, Illinois and Minnesota, and commercial financial services in Indiana, Michigan, Missouri, Ohio and Texas. Associated Bank, N.A. is an Equal Housing Lender, Equal Opportunity Lender and Member FDIC. More information about Associated Banc-Corp is available at www.associatedbank.com.

FORWARD LOOKING STATEMENTS

Statements made in this press release which are not purely historical are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. This includes any statements regarding management’s plans, objectives, or goals for future operations, products or services, and forecasts of its revenues, earnings, or other measures of performance. Such forward-looking statements may be identified by the use of words such as “believe”, “expect”, “anticipate”, “plan”, “estimate”, “should”, “will”, “intend”, “outlook”, “target”, or similar expressions. Forward-looking statements are based on current management expectations and, by their nature, are subject to risks and uncertainties. Actual results may differ materially from those contained in the forward-looking statements. Factors which may cause actual results to differ materially from those contained in such forward-looking statements include those identified in the Company’s most recent Form 10-K and subsequent SEC filings. Such factors are incorporated herein by reference.

Investor Contact: Brian Mathena
Senior Vice President | Director of Investor Relations
920-491-7059 | [email protected]

Media Contact: Jennifer Kaminski
Vice President | Public Relations Senior Manager
920-491-7576 | [email protected]

View original content:http://www.prnewswire.com/news-releases/associated-banc-corp-to-attend-the-2021-kbw-winter-financial-services-symposium-on-february-10–12-2021-301205704.html

SOURCE Associated Banc-Corp

January 11, 2021 6:03 pm

Verde Agritech Announces Change of Auditor

BELO HORIZONTE, Brazil, Jan. 11, 2021 (GLOBE NEWSWIRE) — Verde AgriTech Plc (TSX: “NPK”) (OTCQB: “AMHPF”) (“Verde” or the “Company”) announces that it has changed its auditor from BDO LLP (the “Former Auditor”) to PKF Littlejohn LLP (the “Successor Auditor”). The Former Auditor resigned at the request of the Company effective as of November 27, 2020, and Verde’s Board of Directors appointed the Successor Auditor as the Company’s auditor until the close of the Company’s next annual general meeting.

“We would like to thank BDO LLP for their expertise and guidance and we are pleased to announce that PKF Littlejohn LLP will be an important part of Verde’s story in the next stage of our growth,” said Cristiano Veloso, Verde’s founder, President and CEO.

There have been no reservations contained in Former Auditor’s reports on any of the Company’s financial statements relating to the period during which BDO LLP was the Company’s auditor. There are no reportable events (as defined under section 4.11(1) of NI 51-102).

In accordance with NI 51-102, the notice of change of auditor, together with the required letters from the Former Auditor and the Successor Auditor, have been reviewed by the board of directors of the Company and filed on SEDAR.

Questions & Answers

The Company will host a Q&A conference call on Thursday, January 21, 2021 at 11:30 am Eastern Time (4:30 pm Greenwich Time).

Subscribe at the following link and receive the conference details by email:

Date:	Thursday, January 21, 2021
Time:	11:30 am Eastern Time (4:30 pm Greenwich Mean Time)
Subscription link:	http://bit.ly/QuestionsandAnswers-VerdeAgriTech

The questions can be submitted in advance through the following link:
http://bit.ly/SubmitQuestion-VerdeAgriTech

About Verde AgriTech

Verde AgriTech promotes sustainable and profitable agriculture through the development of its Cerrado Verde Project. Cerrado Verde, located in the heart of Brazil’s largest agricultural market, is the source of a potassium-rich deposit from which the Company intends to produce solutions for crop nutrition, crop protection, soil improvement and increased sustainability.

For additional information please contact:

Cristiano Veloso, President & Chief Executive Officer
Tel: +55 (31) 3245 0205; Email: [email protected]

www.verde.ag | www.supergreensand.com

Cautionary Language and Forward Looking Statements

All Mineral Reserve and Mineral Resources estimates reported by the Company were estimated in accordance with the Canadian National Instrument 43-101 and the Canadian Institute of Mining, Metallurgy, and Petroleum Definition Standards (May 10, 2014). These standards differ significantly from the requirements of the U.S. Securities and Exchange Commission. Mineral Resources which are not Mineral Reserves do not have demonstrated economic viability.

This document contains “forward-looking information” within the meaning of Canadian securities legislation and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995. This information and these statements, referred to herein as “forward-looking statements” are made as of the date of this document. Forward-looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events and include, but are not limited to, statements with respect to:

(i)	the estimated amount and grade of Mineral Resources and Mineral Reserves;
(ii)	the PFS representing a viable development option for the Project;
(iii)	estimates of the capital costs of constructing mine facilities and bringing a mine into production, of sustaining capital and the duration of financing payback periods;
(iv)	the estimated amount of future production, both produced and sold; and,
(v)	estimates of operating costs and total costs, net cash flow, net present value and economic returns from an operating mine.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives or future events or performance (often, but not always, using words or phrases such as “expects”, “anticipates”, “plans”, “projects”, “estimates”, “envisages”, “assumes”, “intends”, “strategy”, “goals”, “objectives” or variations thereof or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be forward-looking statements.

All forward-looking statements are based on Verde’s or its consultants’ current beliefs as well as various assumptions made by them and information currently available to them. The most significant assumptions are set forth above, but generally these assumptions include:

(i)	the presence of and continuity of resources and reserves at the Project at estimated grades;
(ii)	the geotechnical and metallurgical characteristics of rock conforming to sampled results; including the quantities of water and the quality of the water that must be diverted or treated during mining operations;
(iii)	the capacities and durability of various machinery and equipment;
(iv)	the availability of personnel, machinery and equipment at estimated prices and within the estimated delivery times;
(v)	currency exchange rates;
(vi)	Super Greensand® and K Forte® sales prices, market size and exchange rate assumed;
(vii)	appropriate discount rates applied to the cash flows in the economic analysis;
(viii)	tax rates and royalty rates applicable to the proposed mining operation;
(ix)	the availability of acceptable financing under assumed structure and costs;
(x)	anticipated mining losses and dilution;
(xi)	reasonable contingency requirements;
(xii)	success in realizing proposed operations;
(xiii)	receipt of permits and other regulatory approvals on acceptable terms; and
(xiv)	the fulfilment of environmental assessment commitments and arrangements with local communities.

Although management considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect. Many forward-looking statements are made assuming the correctness of other forward-looking statements, such as statements of net present value and internal rates of return, which are based on most of the other forward-looking statements and assumptions herein. The cost information is also prepared using current values, but the time for incurring the costs will be in the future and it is assumed costs will remain stable over the relevant period.

By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that estimates, forecasts, projections and other forward-looking statements will not be achieved or that assumptions do not reflect future experience. We caution readers not to place undue reliance on these forward-looking statements as a number of important factors could cause the actual outcomes to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates assumptions and intentions expressed in such forward-looking statements. These risk factors may be generally stated as the risk that the assumptions and estimates expressed above do not occur as forecast, but specifically include, without limitation: risks relating to variations in the mineral content within the material identified as Mineral Resources and Mineral Reserves from that predicted; variations in rates of recovery and extraction; the geotechnical characteristics of the rock mined or through which infrastructure is built differing from that predicted, the quantity of water that will need to be diverted or treated during mining operations being different from what is expected to be encountered during mining operations or post closure, or the rate of flow of the water being different; developments in world metals markets; risks relating to fluctuations in the Brazilian Real relative to the Canadian dollar; increases in the estimated capital and operating costs or unanticipated costs; difficulties attracting the necessary work force; increases in financing costs or adverse changes to the terms of available financing, if any; tax rates or royalties being greater than assumed; changes in development or mining plans due to changes in logistical, technical or other factors; changes in project parameters as plans continue to be refined; risks relating to receipt of regulatory approvals; delays in stakeholder negotiations; changes in regulations applying to the development, operation, and closure of mining operations from what currently exists; the effects of competition in the markets in which Verde operates; operational and infrastructure risks and the additional risks described in Verde’s Annual Information Form filed with SEDAR in Canada (available at www.sedar.com ) for the year ended December 31, 2019. Verde cautions that the foregoing list of factors that may affect future results is not exhaustive.

When relying on our forward-looking statements to make decisions with respect to Verde, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Verde does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by Verde or on our behalf, except as required by law.

January 11, 2021 6:03 pm

IGM Biosciences Enters into Exclusive Licensing Agreement with Medivir for Birinapant

– IGM to Develop Birinapant in Combination with IGM-8444 for the Treatment of Solid Tumors –

MOUNTAIN VIEW, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS) today announced that it has entered into an exclusive license agreement with Medivir AB (Nasdaq Stockholm: MVIR), through which IGM will receive global, exclusive development and commercialization rights for birinapant, a clinical-stage SMAC mimetic that binds to and degrades Inhibitors of Apoptosis Proteins (IAPs), leading to cell death (apoptosis) in tumor cells. The combination of IGM-8444, an IgM antibody targeting Death Receptor 5 (DR5) being developed by IGM, and birinapant has been shown to enhance anti-tumor activity preclinically.

Under terms of the agreement, Medivir will receive an upfront payment of $1 million upon signing the agreement, followed by an additional $1.5 million when birinapant is included by IGM in clinical Phase I studies. The terms of the agreement also entitle Medivir, should birinapant be successfully developed and approved, to receive milestone payments up to a total of approximately $350 million, plus tiered royalties from the mid-single digits up to mid-teens on net sales.

“Based on our in vitro and in vivo models, which have shown remarkable synergy between IGM-8444 and birinapant, we are excited to explore this combination’s potential to deliver superior anti-tumor activity in patients with solid tumors,” said Fred Schwarzer, Chief Executive Officer of IGM Biosciences. “This agreement is part of a broader strategy to realize the full potential of our IgM drug candidates by maintaining control over the timing and development path of the more promising combinations to emerge from our preclinical and clinical work. We look forward to moving the IGM-8444-birinapant combination into clinical testing to begin validating the significance of targeting DR5 with an IgM antibody in certain combinations and to continue to explore similar strategic options across our IgM platform.”

“Agreements, such as the one announced today with IGM, continue to be a core component of Medivir’s corporate mission and business model,” said Yilmaz Mahshid, Chief Executive Officer of Medivir. “Today’s announcement further exemplifies our focus and commitment to the development and commercialization of innovative treatments for cancer, and we look forward to IGM’s progress in the clinic and beyond.”

In addition to its apoptotic activity, birinapant augments anti-tumor immune system activity. Through this double action, on both tumor cells and cells of the immune system, birinapant has the potential to improve the treatment of several types of cancer when used in combination with other drugs. IGM-8444 is currently being tested in a Phase 1 dose escalation study in patients with solid and hematologic malignancies. DR5 is a member of the tumor necrosis factor receptor superfamily (TNFrSF) and is often expressed on the surface of cancer cells. Subject to regulatory review, IGM plans to begin the clinical testing of birinapant in combination with IGM-8444 for the treatment of solid tumors later this year.

About IGM Biosciences, Inc.

Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

IGM Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements, including statements relating to IGM’s plans, expectations and forecasts and to future events. Such forward-looking statements include, but are not limited to, the potential of, and expectations regarding, birinapant, IGM’s technology platform and antibody drug candidates including IGM-8444 and the combination of birinapant and IGM-8444, the potential safety and efficacy of the combination of birinapant and IGM-8444, statements regarding IGM’s Phase 1 clinical trial of IGM-8444, IGM’s development strategy for IGM-8444 and plans to begin clinical testing of birinapant in combination with IGM-8444 for the treatment of solid tumors, and statements by the Chief Executive Officers of Medivir and IGM. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially, including but not limited to: termination of the license agreement; IGM’s ability to demonstrate the safety and efficacy of IGM-8444 in combination with birinapant; IGM’s ability to successfully and timely advance the combination through preclinical studies and clinical trials; IGM’s ability to enroll patients in its clinical trials; the potential for the results of clinical trials to differ from preclinical or expected results; the risk of significant adverse events, toxicities or other undesirable side effects; IGM’s ability to successfully manufacture and supply its product candidates, including birinapant and IGM-8444, for clinical trials; the risk that all necessary regulatory approvals cannot be obtained; the risk that the potential benefits of the combination do not outweigh their costs; potential delays and disruption resulting from the COVID-19 pandemic and governmental responses to the pandemic, including any future impacts to IGM’s operations, the manufacturing of its product candidates, the progression of its clinical trials, enrollment in its current and future clinical trials and on its collaborations and related efforts; IGM’s early stages of clinical drug development; risks related to the use of engineered IgM antibodies, which is a novel and unproven therapeutic approach; IGM’s ability to obtain additional capital to finance its operations, if needed; uncertainties related to the projections of the size of patient populations suffering from the diseases IGM is targeting; IGM’s ability to obtain, maintain and protect its intellectual property rights; developments relating to IGM’s competitors and its industry, including competing product candidates and therapies; risks related to collaborations with third parties, including the risk of the occurrence of any event, change or other circumstance that could give rise to the termination of any such collaboration; general economic and market conditions; and other risks and uncertainties, including those more fully described in IGM’s filings with the Securities and Exchange Commission (SEC), including IGM’s Annual Report on Form 10-K filed with the SEC on March 26, 2020, IGM’s Quarterly Report on Form 10-Q filed with the SEC on November 5, 2020, IGM’s Current Report on Form 8-K filed with the SEC on December 7, 2020 and in IGM’s future reports to be filed with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and IGM specifically disclaims any obligation to update any forward-looking statement, except as required by law.

Contact:

Argot Partners
David Pitts
212-600-1902
[email protected]

January 11, 2021 5:51 pm

OUTFRONT Media Announces Pricing Of Senior Notes Offering

PR Newswire

NEW YORK, Jan. 11, 2021 /PRNewswire/ — OUTFRONT Media Inc. (NYSE: OUT) today announced that two of its wholly-owned subsidiaries priced a private offering of $500.0 million in aggregate principal amount of 4.250% Senior Notes due 2029 (the “notes”). The notes are to be sold at an issue price of 100.0% of the principal amount. The offering is expected to close on January 19, 2021, subject to customary closing conditions.

OUTFRONT Media intends to use the net proceeds from the notes offering, together with cash on hand, to redeem all of its outstanding 5.625% Senior Notes due 2024 (the “2024 notes”) and to pay accrued and unpaid interest on the 2024 notes, if any, to, but excluding, the redemption date, and to pay fees and expenses in connection with the notes offering and the 2024 notes redemption.

The notes will be guaranteed on a senior unsecured basis by OUTFRONT Media Inc. and each of its direct and indirect subsidiaries that guarantees its senior credit facilities.

The notes were offered and will be sold in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act. The notes have not been, and will not be, registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the notes, nor shall there be any sale of the notes in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

Cautionary Statement Regarding Forward-Looking Statements
OUTFRONT Media Inc. (“we” and “our”) has made statements in this press release that are forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by the use of forward-looking terminology such as “believes,” “expects,” “could,” “would,” “may,” “might,” “will,” “should,” “seeks,” “likely,” “intends,” “plans,” “projects,” “predicts,” “estimates,” “forecast” or “anticipates” or the negative of these words and phrases or similar words or phrases that are predictions of or indicate future events or trends and that do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans or intentions related to our capital resources, portfolio performance and results of operations. Forward-looking statements involve numerous risks and uncertainties and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data or methods that may be incorrect or imprecise and may not be able to be realized. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements: our ability to consummate the notes offering and the 2024 notes redemption on favorable terms, or at all; the use of the net proceeds from the notes offering; the severity and duration of the novel coronavirus (COVID-19) pandemic and any other pandemics, and the impact on our business, financial condition and results of operations; declines in advertising and general economic conditions, including declines caused by the COVID-19 pandemic; competition; government regulation; our ability to implement our digital display platform and deploy digital advertising displays to our transit franchise partners, including the impact of the COVID-19 pandemic; taxes, fees and registration requirements; our ability to obtain and renew key municipal contracts on favorable terms; seasonal variations; acquisitions and other strategic transactions that we may pursue could have a negative effect on our results of operations; dependence on our management team and other key employees; our substantial indebtedness; restrictions in the agreements governing our indebtedness; incurrence of additional debt; interest rate risk exposure from our variable-rate indebtedness; our ability to generate cash to service our indebtedness; cash available for distributions; hedging transactions; diverse risks in our Canadian business; experiencing a cybersecurity incident; changes in regulations and consumer concerns regarding privacy, information security and data, or any failure or perceived failure to comply with these regulations or our internal policies; asset impairment charges for our long-lived assets and goodwill; our failure to remain qualified to be taxed as a real estate investment trust (“REIT”); REIT distribution requirements; availability of external sources of capital; complying with REIT requirements may limit our ability to hedge effectively; failure to meet the REIT income tests as a result of receiving non-qualifying income; and other factors described in our filings with the Securities and Exchange Commission (the “SEC”), including but not limited to the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on February 26, 2020, and in our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2020, filed with the SEC on May 8, 2020. All forward-looking statements in this press release apply as of the date of this press release or as of the date they were made and, except as required by applicable law, we disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors of new information, data or methods, future events or other changes.

About OUTFRONT Media Inc.
OUTFRONT leverages the power of technology, location and creativity to connect brands with consumers outside of their homes through one of the largest and most diverse sets of billboard, transit, and mobile assets in North America. Through its technology platform, OUTFRONT will fundamentally change the ways advertisers engage audiences on-the-go.

Contacts:
Investors:	Media:
Gregory Lundberg	Courtney Richards
(212) 297-6441	(646) 876-9404
[email protected]	[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/outfront-media-announces-pricing-of-senior-notes-offering-301205714.html

SOURCE OUTFRONT Media Inc.

January 11, 2021 5:49 pm

PrairieSky Royalty Announces Conference Call For 2020 Annual Results

CALGARY, Alberta, Jan. 11, 2021 (GLOBE NEWSWIRE) — PrairieSky will release its annual and Q4 2020 results on Monday, February 8, 2021 after markets close. The news release detailing PrairieSky’s Annual and Q4 2020 results will provide operating and financial information. Financial statements, management’s discussion and analysis and the annual information form will be available on PrairieSky’s website at www.prairiesky.com and on SEDAR at www.sedar.com.

A conference call to discuss the results will be held for the investment community on Tuesday, February 9, 2021 beginning at 6:30 am MT (8:30 am ET). To participate in the conference call, approximately 10 minutes prior to the conference call, please dial:

(844) 657-2668 (toll-free in North America)

(612) 979-9882 (International)

About PrairieSky Royalty Ltd.

PrairieSky is a royalty-focused company, generating royalty revenues as petroleum and natural gas are produced from its properties. PrairieSky has a diverse portfolio of properties that have a long history of generating free cash flow and that represent the largest and most concentrated independently-owned fee simple mineral title position in Canada. PrairieSky common shares trade on the Toronto Stock Exchange under the symbol PSK.

FOR FURTHER INFORMATION PLEASE CONTACT:

PrairieSky Royalty Ltd.
Investor Relations
(587) 293-4000

www.prairiesky.com

PDF available: http://ml.globenewswire.com/Resource/Download/c9b98f88-6cac-40bf-bcc2-f6892c5517f2

January 11, 2021 5:48 pm

PyroGenesis Announces Guidance for Q4 2020

MONTREAL, Jan. 11, 2021 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://www.pyrogenesis.com) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to provide guidance for the fourth quarter, and full year, both ending December 31^st, 2020.

Based on preliminary financial information, and subject to year-end closing adjustments, PyroGenesis expects revenue for the fourth quarter 2020 to be between $3 – $5 million, resulting in total revenues for the fiscal year ending 2020 of approximately $14 – $16 million, as compared to $1.07 million (Q4 2019) and $4.8 million (FY 2019), respectively.

The Company also expects earnings per share (“EPS”) for the fourth quarter to be in the range of $0.10 – $0.12, and for the fiscal year ending 2020 of between $0.22 – $0.24 , as compared to a loss of $0.04 (Q4 2019) and a loss of $0.07 (FY 2020), respectively.

The Q4 2020 guidance and actual 2019 results noted above are summarized in the following table below:

	Actual 2019	Guidance 2020
Revenue
Q4	$1.07 MM	$ 14-16 MM
YE	$4.8 MM	$ 22-24 MM
EPS Basic
Q4	($0.04)	$0.10-$0.12
YE	($0.07)	$0.22-$0.24

About PyroGenesis Canada
Inc.

PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m² manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at

www.sedar.com
,
or at

www.otcmarkets.com
.
Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.
Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:

Rodayna Kafal, Vice President, IR/Comms. and Strategic BD
Phone: (514) 937-0002, E-mail: [email protected]

RELATED LINK: http://www.pyrogenesis.com/

January 11, 2021 5:46 pm

Generation Bio Announces Closing of Public Offering

CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, today announced the closing of its public offering of 9,200,000 shares of its common stock at a public offering price of $24.50 per share, including 1,200,000 additional shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares. All of the shares in the offering were sold by Generation Bio.

The gross proceeds of the offering, before deducting the underwriting discount and commissions and other offering expenses payable by Generation Bio, were approximately $225.4 million.

J.P. Morgan, Jefferies, and Cowen acted as joint bookrunning managers for the offering. Wedbush PacGrow acted as lead manager for the offering.

A registration statement relating to the securities being sold in this offering was filed with, and declared effective by, the Securities and Exchange Commission (the “SEC”). Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov. This offering was made only by means of a prospectus. Copies of the final prospectus relating to this offering may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone by calling collect at (212) 834-4533, or by email at [email protected]; Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at (877) 821-7388, or by email at [email protected]; or Cowen and Company, LLC, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus Department, or by telephone at (833) 297-2926, or by email at [email protected].

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any offer or sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About Generation Bio

Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.

Contact:

Investors

Maren Killackey
Generation Bio
541-646-2420
[email protected]

Media

Alicia Webb
Generation Bio
847-254-4275
[email protected]

Stephanie Simon
Ten Bridge Communications
617-581-9333
[email protected]

January 11, 2021 5:43 pm

CORRECTING and REPLACING CES 2021: Intel Announces Four New Processor Families

CORRECTING and REPLACING CES 2021: Intel Announces Four New Processor Families

Delivering the Best Business, Education, Mobile and Gaming Computing Platforms for More Than 500 New PC Designs Coming in 2021

NEWS HIGHLIGHTS

At its CES news conference, Intel highlighted how it is driving technology leadership with the introduction of more than 50 processors, resulting in more than 500 new designs for laptops and desktops coming to market in 2021.
Intel launched the 11th Gen Intel^® Core™ vPro^® platform and Intel^® Evo™ vPro^® platform, delivering the highest performance and most comprehensive hardware-based security¹.
Intel introduced the new N-series 10-nanometer Intel^® Pentium^® Silver and Intel^® Celeron^® processors that offer an unmatched balance of performance, media and collaboration for education systems.
Intel announced a new line of 11th Gen Intel^® Core™ H-series mobile processors for gaming platforms that deliver an industry-leading balance of mobility and enthusiast-level gaming.
Intel also previewed products coming to market later in 2021, including 11th Gen Intel^® Core™ S-series desktop processors (code-named “Rocket Lake-S”) and its next-generation processors (code-named “Alder Lake”).

SANTA CLARA, Calif.–(BUSINESS WIRE)–
A multimedia asset accompanying this release has been removed.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210111005970/en/

Intel Executive Vice President Gregory Bryant outlines in Intel’s CES 2021 news conference how the company is introducing new processors for business, education, mobile and gaming computing platforms – all designed to offer the premium PC experiences people deserve, with the most choices and no limits. As part of the all-virtual CES 2021, Intel makes clear that now is the time to “Go and Do Something Wonderful.” (Credit: Intel Corporation)

The release reads:

CES 2021: INTEL ANNOUNCES FOUR NEW PROCESSOR FAMILIES

In a world where computing is pervasive and intelligence is distributed across every surface – from the cloud to the network to the intelligent edge – Intel today at CES 2021 highlighted how it is driving technology leadership to define the future of computing for people, business and society.

To help people navigate through this extraordinary time, Intel introduced new processors for business, education, mobile and gaming computing platforms – all designed to offer the premium PC experiences people deserve, with the most choices and no limits.

More:Intel at CES 2021 (Press Kit) | Mobileye Innovation Will Bring AVs to Everyone, Everywhere (News Release) | 11th Gen Intel vPro Platform (Product Brief) | 11th Gen Intel Core H Series Processors (Product Brief) | 11th Gen Intel Core H Series Processors for Ultraportable Gaming (Press Deck)

“Only Intel has the breadth of products spanning multiple architectures; the large, open ecosystem; sheer scale of manufacturing footprint; and deep technical expertise customers need to unlock opportunities in this era of distributed intelligence,” said Intel Executive Vice President Gregory Bryant. “With an intense focus on execution for our core products and across our broader portfolio, we’re introducing a series of leadership products at CES with more following throughout the year.”

Introducing 11th Gen Intel^® Core™ vPro^®: The Best Platform for Business

For business, Intel introduced the 11th Gen Intel vPro platform, an unrivaled business platform delivering the industry’s highest performance and world’s most comprehensive hardware-based security². The new 11th Gen Intel Core vPro processors unveiled today are based on the world’s best business processor for thin-and-light laptops² and, when combined with the new Intel Core vPro platform, offer:

Intel® Hardware Shield, providing the world’s most comprehensive security deep in hardware for business³ and the industry’s first silicon-enabled artificial intelligence (AI) threat detection to help stop ransomware and crypto-mining attacks. It is also equipped with Intel® Control Flow Enforcement Technology, ground-breaking technology to help shut down an entire class of attacks that long evaded software-only solutions⁴.
Intel 10-nanometer (nm) SuperFin technology, delivering industry-leading performance, Intel® Iris® X^e graphics and the world’s biggest Wi-Fi improvement in 20 years – with integrated Intel® Wi-Fi 6/6E (Gig+) that enables up to six times faster uploads and downloads in the office and nearly three times faster speeds at home versus standard Wi-Fi 5⁵.
Eight times⁶ better AI performance, enabling businesses new compute power to keep pace with the fast-changing software ecosystem, and up to 2.3 times faster⁷ creation and video editing compared to the previous generation.
Up to 23% faster productivity⁸ than the competition when using apps like Office 365 and the best business collaboration experience, enabling more than 50% faster⁹ office productivity compared to the competition while on a video conference call.

Intel also launched the Intel® Evo™ vPro® platform, the best laptop experience for business users¹⁰. Laptop designs verified on the Intel Evo vPro platform are stylish, thin and light and provide an amazing immersive visual experience. They also offer remarkable responsiveness, instant wake and real-world battery life. More than 60 new laptops from top manufacturers will be available this year, combining the security and manageability of vPro and the amazing on-the-go experiences of Intel Evo. Additionally, Intel announced Intel Evo Chromebooks, enabling a new class of premium Chromebooks.

New Processors and Partnerships for Best Education Platform

Use of the PC as an essential education tool has accelerated greatly worldwide over the past year. To meet the growing needs of students, Intel introduced new N-series Intel^® Pentium^® Silver and Celeron^® processors with an unmatched balance of performance, media and collaboration for education systems. The processors are designed on Intel’s 10nm architecture, delivering up to 35%¹¹ better overall application performance and up to 78% better graphics performance gen on gen. This enables smooth application performance and browsing while multitasking, plus advanced camera and connectivity features for an enriched video conferencing and viewing experience.

As critical as advancing technology for meeting students’ evolving needs is putting laptops in their hands. Even with accelerated adoption, up to 30% of U.S. school children still lack internet or laptops for learning, and the pandemic has only exacerbated those requirements. During the last 15 years, Intel has invested more than $1 billion globally in education, including training for more than 15 million teachers. Last April, Intel launched the Online Learning Initiative and has provided hundreds of thousands of devices, as well as connectivity and resources, to students worldwide. Intel will continue these efforts in 2021 along with partners from inside and outside the technology industry.

New Line of 11th Gen Intel® Core™ H-series Mobile Processors for the Best Gaming Platforms

Intel launched a new line of 11th Gen Intel Core H-series mobile processors for gaming that extends the 11th Gen mobile family of products and pushes the limits of what’s possible for enthusiast-level gaming in laptops as thin as 16 millimeters. Led by the Intel® Core™ i7 Special Edition 4-core processor with up to 5 gigahertz (GHz) Turbo, these H35 processors are specifically targeted for ultraportable gaming. They feature new Gen 4 PCIE architecture for connecting to latest discrete graphics and deliver amazingly low latency and immersive game play on the go. At CES, Acer, ASUS, MSI and Vaio announced new systems powered by the 11th Gen Intel Core H35-series processor for ultraportable gaming, with more than 40 designs from top manufacturing partners launching in the first half of 2021.

For mobile enthusiasts who want desktop-caliber gaming and creation performance, Intel also announced an 8-core processor that will start shipping later this quarter. This platform is unique in the industry with features that would normally only be found in high-end desktop systems – including up to 5GHz, 20 lanes of PCIe Gen 4.0 architecture for fastest storage and discrete graphics, and Intel® Killer™ Wi-fi 6E (Gig+).

Preview of Next-Generation “Rocket Lake” and “Alder Lake” Technologies for Leadership Desktop and Mobile Platforms

Intel also demonstrated next-generation desktop technology for gamers and enthusiasts coming to market in 11th Gen Intel® Core™ S-series desktop processors (“Rocket Lake-S”). Featuring 19% gen-over-gen instructions per cycle (IPC) improvement¹² for the highest frequency cores and headlined by the Intel Core i9-11900K, these processors will bring even more performance to gamers and PC enthusiasts at launch in the first quarter of 2021.

Additionally, Intel demonstrated “Alder Lake,” the next-generation processor that represents a significant breakthrough in x86 architecture and Intel’s most power-scalable system-on-chip. Due in second half of 2021, Alder Lake will combine high-performance cores and high-efficiency cores into a single product. Alder Lake will also be Intel’s first processor built on a new, enhanced version of 10nm SuperFin and will serve as the foundation for leadership desktop and mobile processors that deliver smarter, faster and more efficient real-world computing.

About Intel

Intel (Nasdaq: INTC) is an industry leader, creating world-changing technology that enables global progress and enriches lives. Inspired by Moore’s Law, we continuously work to advance the design and manufacturing of semiconductors to help address our customers’ greatest challenges. By embedding intelligence in the cloud, network, edge and every kind of computing device, we unleash the potential of data to transform business and society for the better. To learn more about Intel’s innovations, go to newsroom.intel.com and intel.com.

¹In thin & light Windows-based devices, based on 1) unique features and performance testing on industry benchmarks and Representative Usage Guides across 3 key usages: productivity, creation, and collaboration, comparing Intel® Core™ vPro® i7-1185G7 to AMD Ryzen 7 PRO 4750U and 2) an IOActive study (commissioned by Intel) comparing Intel® Hardware Shield security capabilities on 11th Gen Intel Core vPro processors with corresponding competitor technologies. All testing as of December 2020. Visit www.Intel.com/11thgenvpro for details. Results may vary.

²In thin & light Windows-based devices, based on unique features and performance testing (as of December 1, 2020) on industry benchmarks and Representative Usage Guides across 3 key usages: productivity, creation, and collaboration of Intel® Core™ vPro® i7-1185G7, including in comparison to AMD Ryzen 7 PRO 4750U. Visit www.Intel.com/11thgenvpro for details. Results may vary.

³In thin & light Windows-based devices, based on unique features and testing by IOActive (commissioned by Intel; as of December 2020) comparing Intel® Hardware Shield security capabilities with corresponding technologies in an AMD Ryzen Pro 4750U-based system. Visit www.intel.com/11thgenvpro for details. Results may vary.

⁴Intel Control-flow Enforcement Technology (CET) is designed to help protect against jump/call-oriented programming (JOP/COP) attack methods and return-oriented programming (ROP) attack methods, malware known as memory safety issues and which comprise over half of ZDI-disclosed vulnerabilities. Visit www.intel.com/11thgenvpro for details. Results may vary.

⁵For more information about the data presented, visit www.intel.com/wifi6disclaimers.

⁶As measured by MLPerf v0.7 Inference, Mobile Notebooks, Closed Division with Offline Scenario using OpenVINO 2021.1 Pre framework on MobileNetEdge model int8 GPU (Batch=16) on 11th Gen Intel® Core™ i7-1185G7 Processor vs highest attainable MLPerfv0.7 Inference, Mobile Notebooks, Closed Division with Offline Scenario using OpenVINO 2021.1 Pre framework on MobileNetEdge model int8 GPU (Batch=1) on 10th Gen Intel® Core™ vPro® i7-10810U processor

⁷As measured by Video Editing workflow. 11th Gen Intel® Core™ vPro® i7-1185G7 Processor vs. 10th Gen Intel® Core™ vPro® i7-10610U Processor

⁸As measured by Microsoft Office 365 workflow. 11th Gen Intel® Core™ vPro® i7-1185G7 Processor vs. MD Ryzen 7 PRO 4750U

⁹As measured by Productivity and Collaboration Workflow. 11th Gen Intel® Core™ vPro® i7-1185G7 Processor vs. AMD Ryzen 7 PRO 4750U

¹⁰In thin & light Windows-based devices, based on 1) unique features and performance testing on industry benchmarks and Representative Usage Guides across 3 key usages: productivity, creation, and collaboration, comparing Intel® Core™ vPro® i7-1185G7to AMD Ryzen 7 PRO 4750U and 2) an IOActive study (commissioned by Intel) comparing Intel® Hardware Shield security capabilities on 11th Gen Intel Core vPro processors with corresponding competitor technologies. All testing as of December 2020. Intel Evo vPro designs are co-engineered as part of Intel’s comprehensive laptop innovation program Project Athena then tested, measured, and verified against a premium specification and key experience indicators to ensure unparalleled user experiences. Visit www.Intel.com/11thgenvpro for details. Results may vary.

¹¹Source: Intel estimates as of January 2021. Based on measurements on Intel Pentium Silver and Celeron measured on platforms with Intel® Pentium® Silver N6000 Processor, PL1=6W TDP, PL2 = 20W 4C4T, Turbo up to 3.3GHz, Motherboard: JSL RVP, Graphics: Intel® UHD Graphics 605, Memory: 2x4GB DDR4- 3200, Storage: 512GB Intel SSD 660P, OS: Windows* 10 20 H1, OS Version 19041.546, BIOS : 2385.02_140 vs. Intel® Pentium® N5030 Processor, PL1=6W TDP, PL2 = 15W 4C4T, Turbo up to 3.1GHz, Motherboard: GLK RVP, Graphics: Intel® UHD Graphics 605, Memory: 2x4GB DDR4 -2400, Storage: 256GB Intel® SSD 540s Series, OS: Windows* 10 19H1, OS Version: 10.0.19041.630 BIOS : 0064_42

¹²Source: Intel estimates as of January 2021. Based on measurements on Intel Internal reference platforms running SPEC CPU 2017 1-copy rate on 11th Gen Intel® Core™ i9-11900K vs 10th Gen Intel® Core™ i9-10900K (running each at the same fixed frequency).

Performance varies by use, configuration and other factors. Learn more at intel.com/PerformanceIndex.

Performance results are based on testing as of dates shown in configurations and may not reflect all publicly available updates. See CES 2021 Claim Appendix on intel.com/PerformanceIndex for configuration details. No product or component can be absolutely secure.

Your costs and results may vary.

Intel technologies may require enabled hardware, software or service activation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210111005970/en/

Daniel Francisco

916-377-9509

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Technology Hardware Security Consumer Electronics

MEDIA:

Logo

Photo

Intel Vice President Stephanie Hallford, who leads Business Client Platforms, unveils at CES 2021 the new 11th Gen Intel Core vPro platform and Intel Evo vPro platform, delivering the highest performance and most comprehensive hardware-based security. As part of the all-virtual CES 2021, Intel makes clear that now is the time to “Go and Do Something Wonderful.” (Credit: Intel Corporation)

Photo

At CES 2021, Intel introduces four new families of processors — from entry to premium — that include 27 new CPUs built specifically for business, six new CPUs for education, 12 high-performance mobile CPUs, and eight high-performance desktop CPUs. The result is more than 500 new designs for laptops and desktops that will come to market in 2021. As part of the all-virtual CES 2021, Intel makes clear that now is the time to “Go and Do Something Wonderful.” (Credit: Intel Corporation)

Photo

11th Gen Intel Core desktop processors (code-named “Rocket Lake-S”) will deliver increased performance and speeds. They will launch in the first quarter of 2021. (Credit: Intel Corporation)

January 11, 2021 5:33 pm

Sonoma Pharmaceuticals to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference

Sonoma Pharmaceuticals to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference

WOODSTOCK, Ga.–(BUSINESS WIRE)–
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that CEO Amy Trombly and CFO Jerry Dvonch will present at the H.C. Wainwright Bioconnect 2021 Virtual Conference taking place January 11-14, 2021.

The presentation is available for on-demand listening beginning at 6:00 AM Eastern Time on Monday, January 11, 2021, through close of business January 14, 2021. For those interested in viewing Sonoma’s presentation, registration can be accessed here. In addition, the presentation was furnished on a current report on Form 8-K with the U.S. Securities and Exchange Commission via EDGAR.

About Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at www.sonomapharma.com. For partnership opportunities, please contact [email protected].

Forward-Looking Statements

Except for historical information herein, matters set forth in this press release are forward-looking within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial and technology progress and future financial performance of Sonoma Pharmaceuticals, Inc. and its subsidiaries (the “company”). These forward-looking statements are identified by the use of words such as “continue,” “develop” and “expand,” among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the company’s business that could cause actual results to vary, including such risks that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by the company’s patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for the company’s products will not be as large as expected, the company’s products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company’s cash needs, fund further development, as well as uncertainties relative to the COVID-19 pandemic and economic development, varying product formulations and a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in the company’s filings with the Securities and Exchange Commission. The company disclaims any obligation to update these forward-looking statements, except as required by law.

Sonoma Pharmaceuticals™ is a trademark or registered trademarks of Sonoma Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210111005993/en/

Media and Investor Contact:

Sonoma Pharmaceuticals, Inc.

[email protected]

KEYWORDS: Georgia United States North America

INDUSTRY KEYWORDS: General Health Pharmaceutical Health Medical Supplies

MEDIA:

Logo

January 11, 2021 5:33 pm

Bryn Mawr Bank Corporation Announces Date of Fourth Quarter 2020 Financial Results and Earnings Call

BRYN MAWR, Pa., Jan. 11, 2021 (GLOBE NEWSWIRE) — Bryn Mawr Bank Corporation (NASDAQ: BMTC) (the “Corporation”), parent of The Bryn Mawr Trust Company, expects to report fourth quarter 2020 financial results after markets close on Thursday, January 21, 2021.

The Corporation will hold a fourth quarter 2020 earnings conference call at 8:30 a.m. Eastern Time on Friday, January 22, 2021. Interested parties may participate by calling 1-888-317-6016. A taped replay of the conference call will be available one hour after the conclusion of the call and will remain available through 9:00 a.m. Eastern Time on Monday, February 22, 2021. This recording may be obtained by calling 1-877-344-7529, referring to conference number 10151203.

The Corporation will simultaneously broadcast the earnings conference call live over the Internet through a webcast on the investor relations portion of the Corporation’s website. To access the call via the Internet, please visit the website at http://services.choruscall.com/links/bmtc210122.html. An online archive of the webcast will be available within one hour of the conclusion of the earnings conference call. Within 24 hours after the conclusion of the earnings conference call, an online transcript will be available at the following website: https://www.b m t.com/investors/presentations /.

The Corporation’s decision to hold an earnings conference call for the fourth quarter of 2020 is not indicative of the Corporation’s future plans with respect to earnings conference calls, and decisions regarding whether to continue holding earnings conference calls will be made at a future date.

About Bryn Mawr Bank Corporation

Bryn Mawr Bank Corporation (the “Corporation”) (NASDAQ: BMTC), is the holding company for The Bryn Mawr Trust Company which was founded in 1889, and is headquartered in Bryn Mawr, Pa. BMT is a locally managed, premier financial services company providing retail and commercial banking; trust administration and wealth management; and insurance and risk management solutions. Bryn Mawr Bank Corporation has $5.05 billion in corporate assets and $17.24 billion in wealth assets under management, administration, supervision, and brokerage (as of 9/30/2020). The company operates 41 banking locations, 7 wealth management offices and 2 insurance and risk management locations in the following counties: Montgomery, Chester, Delaware, Philadelphia, and Dauphin Counties in Pennsylvania; New Castle County in Delaware; and Mercer and Camden Counties in New Jersey. For more information, visit bmt.com.

FORWARD LOOKING STATEMENTS AND SAFE HARBOR

This communication contains statements which, to the extent that they are not recitations of historical fact may constitute forward-looking statements for purposes of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. Such forward-looking statements may include financial and other projections as well as statements regarding the Corporation’s future plans, objectives, performance, revenues, growth, profits, operating expenses or the Corporation’s underlying assumptions. The words “may,” “would,” “should,” “could,” “will,” “likely,” “possibly,” “expect,” “anticipate,” “intend,” “indicate,” “estimate,” “target,” “potentially,” “promising,” “probably,” “outlook,” “predict,” “contemplate,” “continue,” “plan,” “strategy,” “forecast,” “project,” “are optimistic,” “are looking,” “are looking forward” and “believe” or other similar words and phrases may identify forward-looking statements. Persons reading this communication are cautioned that such statements are only predictions, and that the Corporation’s actual future results or performance may be materially different.

Such forward-looking statements involve known and unknown risks and uncertainties. A number of factors, many of which are beyond the Corporation’s control, could cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments expressed, implied or anticipated by such forward-looking statements, and so our business and financial condition and results of operations could be materially and adversely affected. The COVID-19 pandemic (the “Pandemic”) is adversely affecting us, our clients, counterparties, employees, and third-party service providers, and the ultimate extent of the impacts on our business, financial position, results of operations, liquidity, and prospects is uncertain. Continued deterioration in general business and economic conditions, including further increases in unemployment rates, or turbulence in domestic or global financial markets could adversely affect our revenues and the values of our assets and liabilities, reduce the availability of funding, lead to a tightening of credit, and further increase stock price volatility. In addition, changes to statutes, regulations, or regulatory policies or practices as a result of, or in response to the Pandemic, could affect us in substantial and unpredictable ways. Other factors include, among others, our need for capital, our ability to control operating costs and expenses, and to manage loan and lease delinquency rates; the credit risks of lending activities and overall quality of the composition of our loan, lease and securities portfolio; the impact of economic conditions, consumer and business spending habits, and real estate market conditions on our business and in our market area; changes in the levels of general interest rates, deposit interest rates, or net interest margin and funding sources; changes in banking regulations and policies and the possibility that any banking agency approvals we might require for certain activities will not be obtained in a timely manner or at all or will be conditioned in a manner that would impair our ability to implement our business plans; changes in accounting policies and practices or accounting standards, including ASU 2016-13 (Topic 326), “Measurement of Credit Losses on Financial Instruments,” commonly referenced as the Current Expected Credit Loss model, which has changed how we estimate credit losses and may result in further increases in the required level of our allowance for credit losses; unanticipated regulatory or legal proceedings, outcomes of litigation or other contingencies; cybersecurity events; the inability of key third-party providers to perform their obligations to us; our ability to attract and retain key personnel; competition in our marketplace; war or terrorist activities; material differences in the actual financial results, cost savings and revenue enhancements associated with our acquisitions; uncertainty regarding the future of LIBOR; the impact of public health issues and pandemics, and their effects on the economic and business environments in which we operate, the effect of the Pandemic, including on our credit quality and business operations, as well as its impact on general economic and financial market conditions; and other factors as described in our securities filings with the U.S. Securities and Exchange Commission (“SEC”). All forward-looking statements and information set forth herein are based on Corporation management’s current beliefs and assumptions as of the date hereof and speak only as of the date they are made. The Corporation does not undertake to update forward-looking statements.

For a complete discussion of the assumptions, risks and uncertainties related to our business, you are encouraged to review our filings with the SEC, including our most recent Annual Report on Form 10-K, as updated by our quarterly or other reports subsequently filed with the SEC, including our most recent Quarterly Report on Form 10-Q.

FOR MORE INFORMATION

Frank Leto, President, CEO
610-581-4730
Mike Harrington, CFO
610-526-2466